3 Reasons to Avoid WW and 1 Stock to Buy InsteadThe past six months haven’t been great for WeightWatchers. It just made a new 52-week low of $0.16, and shareholders have lost 88.9% of their capital. This may have investors wondering how to approach the situation.
Kimball Electronics (KE): Buy, Sell, or Hold Post Q4 Earnings?What a brutal six months it’s been for Kimball Electronics. The stock has dropped 24.9% and now trades at $13.49, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Avoid NDSN and 1 Stock to Buy InsteadWhat a brutal six months it’s been for Nordson. The stock has dropped 27.9% and now trades at $185.50, rattling many shareholders. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Interpublic Group (IPG): Buy, Sell, or Hold Post Q4 Earnings?Interpublic Group has gotten torched over the last six months - since October 2024, its stock price has dropped 20.5% to $25.03 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Estée Lauder (EL): Buy, Sell, or Hold Post Q4 Earnings?Estée Lauder has gotten torched over the last six months - since October 2024, its stock price has dropped 41.8% to $55.23 per share. This might have investors contemplating their next move.
3 Reasons to Sell CROX and 1 Stock to Buy InsteadCrocs has gotten torched over the last six months - since October 2024, its stock price has dropped 29.2% to $96.76 per share. This may have investors wondering how to approach the situation.
Xponential Fitness (XPOF): Buy, Sell, or Hold Post Q4 Earnings?Xponential Fitness has gotten torched over the last six months - since October 2024, its stock price has dropped 39.6% to $7.43 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
ON24 (ONTF): Buy, Sell, or Hold Post Q4 Earnings?ON24 trades at $4.99 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 17.9% while the S&P 500 is down 13.5%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Bel Fuse (BELFA): Buy, Sell, or Hold Post Q4 Earnings?Bel Fuse’s stock price has taken a beating over the past six months, shedding 54.9% of its value and falling to a new 52-week low of $46 per share. This might have investors contemplating their next move.
Commercial Vehicle Group (CVGI): Buy, Sell, or Hold Post Q4 Earnings?What a brutal six months it’s been for Commercial Vehicle Group. The stock has dropped 68.8% and now trades at $0.95, rattling many shareholders. This might have investors contemplating their next move.
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings?What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons MED is Risky and 1 Stock to Buy InsteadWhat a brutal six months it’s been for Medifast. The stock has dropped 29.3% and now trades at $13.05, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Sell ROKU and 1 Stock to Buy InsteadShareholders of Roku would probably like to forget the past six months even happened. The stock dropped 25.4% and now trades at $58.60. This may have investors wondering how to approach the situation.
3 Reasons to Sell OSK and 1 Stock to Buy InsteadAlthough the S&P 500 is down 10.6% over the past six months, Oshkosh’s stock price has fallen further to $84.35, losing shareholders 15.8% of their capital. This might have investors contemplating their next move.
3 Reasons to Avoid JJSF and 1 Stock to Buy InsteadWhat a brutal six months it’s been for J&J Snack Foods. The stock has dropped 20.8% and now trades at $133, rattling many shareholders. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
MarineMax (HZO): Buy, Sell, or Hold Post Q4 Earnings?MarineMax has gotten torched over the last six months - since October 2024, its stock price has dropped 40.9% to a new 52-week low of $17.84 per share. This might have investors contemplating their next move.
3 Reasons POST is Risky and 1 Stock to Buy InsteadPost has been treading water for the past six months, recording a small return of 2.7% while holding steady at $117.55. However, the stock is beating the S&P 500’s 7% decline during that period.
3 Reasons to Avoid UTI and 1 Stock to Buy InsteadUniversal Technical Institute has been on fire lately. In the past six months alone, the company’s stock price has rocketed 67.9%, reaching $25.88 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid MMSI and 1 Stock to Buy InsteadSince April 2020, the S&P 500 has delivered a total return of 121%. But one standout stock has doubled the market - over the past five years, Merit Medical Systems has surged 247% to $105.49 per share. Its momentum hasn’t stopped as it’s also gained 10% in the last six months, beating the S&P by 13.3%.
3 Reasons to Avoid RHI and 1 Stock to Buy InsteadOver the past six months, Robert Half’s shares (currently trading at $55.99) have posted a disappointing 15.8% loss while the S&P 500 was down 3.3%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
2 Reasons to Like YUM and 1 to Stay SkepticalWhile the broader market has struggled with the S&P 500 down 1.7% since October 2024, Yum! Brands has surged ahead as its stock price has climbed by 13.6% to $158.53 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell ARCO and 1 Stock to Buy InsteadOver the past six months, Arcos Dorados’s shares (currently trading at $8.42) have posted a disappointing 14.6% loss while the S&P 500 was down 1.7%. This might have investors contemplating their next move.
3 Reasons to Sell G and 1 Stock to Buy InsteadEven during a down period for the markets, Genpact has gone against the grain, climbing to $50.06. Its shares have yielded a 27.5% return over the last six months, beating the S&P 500 by 29.2%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Avoid INTC and 1 Stock to Buy InsteadIntel has been treading water for the past six months, holding steady at $22.65.
3 Reasons FFIV is Risky and 1 Stock to Buy InsteadEven during a down period for the markets, F5 has gone against the grain, climbing to $266. Its shares have yielded a 21.7% return over the last six months, beating the S&P 500 by 23.4%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
